Majstorov, Venijamin and PopGorceva, Daniela and Vavlukis, Marija and Peovska, Irena and Maksimovik, Jelena and Vaskova, Olivija and Kuzmanovska, Sonja and Zdraveska-Kochovska, Marina (2008) N-terminal-proB natriuretic peptide in patients with stable coronary artery disease evaluated for ischemia with myocardial perfusion imaging. Bratislavské lekárske listy, 109 (7). pp. 293-7. ISSN 0006-9248
Text
18792482 - Published Version Download (77kB) |
|
Preview |
Text
Nterminal proBNP.pdf Download (159kB) | Preview |
Abstract
BACKGROUND
Natriuretic peptides have emerged in the last years as useful diagnostic and prognostic biomarkers in patients with stable CAD. Myocardial ischemia per se might increase NT-proBNP levels.
OBJECTIVES
The aim of the present study was to determine whether NT-proBNP levels in patients with stable CAD and preserved left ventricular function are elevated and second, to compare NT-proBNP in patients with verified ischemia on myocardial perfusion imaging (MPI) to non-ischemic subjects with known CAD.
METHODS
117 patients were prospectively included, divided in two groups: group A (26 patients)--with normal MPI and without known CAD and group B (91 patients)--with abnormal MPI or known CAD. Patients from group B were further divided according to the presence of ischemia on MPI in non-ischemic (29 pts) and ischemic (62 pts) subgroup.
RESULTS
Levels of NT-proBNP in group B were significantly higher compared to group A (median 53 vs 21 pg/ ml, p = 0.012). End diastolic and end systolic volumes were higher, and ejection fraction after stress and at rest was lower in group B (63% vs 71%, p = 0.0004 and 69% vs 75%, p = 0.008). No significant difference in NT-pro BNP levels (median 48 vs 62 pg/ml, p = 0.5) and functional parameters between the ischemic and nonischemic subjects was found.
CONCLUSION
Our data show that patients with stable coronary artery disease and preserved left ventricular function have elevated levels of NT-proBNP. We could not demonstrate that the presence of myocardial ischemia per se was an additional factor leading to increase of the natriuretic propeptide (Tab. 4, Ref. 12).
Item Type: | Article |
---|---|
Subjects: | Medical and Health Sciences > Clinical medicine |
Divisions: | Faculty of Medical Science |
Depositing User: | Marija Vavlukis |
Date Deposited: | 13 Aug 2015 12:45 |
Last Modified: | 13 Aug 2015 12:45 |
URI: | https://eprints.ugd.edu.mk/id/eprint/13667 |
Actions (login required)
View Item |